Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Assets Average (2016 - 2025)

Historic Assets Average for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to $2.6 billion.

  • Ptc Therapeutics' Assets Average rose 4042.11% to $2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 4042.11%. This contributed to the annual value of $1.8 billion for FY2024, which is 1.65% down from last year.
  • As of Q3 2025, Ptc Therapeutics' Assets Average stood at $2.6 billion, which was up 4042.11% from $2.6 billion recorded in Q2 2025.
  • Over the past 5 years, Ptc Therapeutics' Assets Average peaked at $2.6 billion during Q2 2025, and registered a low of $1.3 billion during Q3 2023.
  • Over the past 5 years, Ptc Therapeutics' median Assets Average value was $1.9 billion (recorded in 2024), while the average stood at $1.9 billion.
  • As far as peak fluctuations go, Ptc Therapeutics' Assets Average tumbled by 2314.62% in 2023, and later soared by 4467.2% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Assets Average (Quarter) stood at $2.0 billion in 2021, then fell by 16.81% to $1.6 billion in 2022, then fell by 3.85% to $1.6 billion in 2023, then rose by 12.41% to $1.8 billion in 2024, then surged by 48.79% to $2.6 billion in 2025.
  • Its Assets Average was $2.6 billion in Q3 2025, compared to $2.6 billion in Q2 2025 and $2.2 billion in Q1 2025.